Roxane Bunod
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Roxane Bunod has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
C. Baudouin
Service d'ophtalmologie 3, IHU FOReSIGHT, centre hospitalier national des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France; CHNO des Quinze-Vingts, IHU FOReSIGHT, INSERM-DGOS CIC 1423, 17, rue Moreau, 75012 Paris, France; Sorbonne universités, INSERM, CNRS, institut de la Vision, 17, rue Moreau, 75012 Paris, France; Service d'ophtalmologie, hôpital Ambroise-Paré, AP-HP, université de Paris Saclay, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France
2 shared publicationsA. Labbe
Service d'ophtalmologie 3, IHU FOReSIGHT, centre hospitalier national des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France; CHNO des Quinze-Vingts, IHU FOReSIGHT, INSERM-DGOS CIC 1423, 17, rue Moreau, 75012 Paris, France; Sorbonne universités, INSERM, CNRS, institut de la Vision, 17, rue Moreau, 75012 Paris, France; Service d'ophtalmologie, hôpital Ambroise-Paré, AP-HP, université de Paris Saclay, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France
1 shared publicationA. Labbé
Department of Ophthalmology 3, Quinze-Vingts National Ophthalmology Hospital, 28, rue de Charenton, 75012 Paris, France; CHNO des Quinze-Vingts, IHU FOReSIGHT, INSERM-DGOS CIC 1423, 17, rue Moreau, 75012 Paris, France; Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17, rue Moreau, 75012 Paris, France; Department of Ophthalmology, Ambroise Paré Hospital, University of Versailles Saint-Quentin-en-Yvelines, AP-HP, 9, avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France
1 shared publication- Alexandra Miere
Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris Est Créteil, Créteil, France; and
1 shared publication - Alexandra Mouallem-Beziere
Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, University Paris Est Créteil, 94000 Créteil, France
1 shared publication Antoine Labbé
Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, Paris, France
1 shared publication
Latest Publications
- 3 January 2022
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 45 (2) , 216-232
Intelligence artificielle et glaucome : une revue de la littérature
- 3 January 2022
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 45 (2) , 216-232
Intelligence artificielle et glaucome : une revue de la littérature
- 1 November 2021
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 44 (9) , 1362-1369
Evaluation of pterygium severity with en face anterior segment optical coherence tomography and correlations with in vivo confocal microscopy
- 1 November 2021
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 44 (9) , 1362-1369
Evaluation of pterygium severity with en face anterior segment optical coherence tomography and correlations with in vivo confocal microscopy
- Open Access
- 10 July 2021
- Published by Springer Nature in BMC Ophthalmology
- Vol. 21 (1) , 1-7
PreserFlo MicroShunt® exposure: a case series
Background: PreserFlo® MicroShunt (PM) (also known as InnFocus® MicroShunt) is a subconjunctival stent implanted ab externo via a minimally invasive surgical procedure. The current indication is progressive, mild to moderate, open angle glaucoma uncontrolled on topical medications. According to the literature, adverse events are rare, mild and transient. Case presentation: Two cases of stand-alone PreserFlo MicroShunt® implantation in patients with uncontrolled open-angle glaucoma are reported. Exposure occurred 7 days and 3 months respectively after implantation. These cases shared common features including preexisting blepharitis and the lack of a Tenon’s flap. In both cases, removal of the device was required after several attempts at repair. Conclusions: PreserFlo MicroShunt® exposure is a potentially vision-threatening complication because of the risk of endophthalmitis. Potential risk factors include the absence of a Tenon’s flap and pre-existing ocular surface inflammation. Ocular surface inflammation should be detected and treated prior to PM implantation. If a deficiency in Tenon’s capsule is noted intraoperatively, close monitoring should be performed because of the higher risk of PM exposure.
- 10 July 2021
- Published by Springer Nature in BMC Ophthalmology
- Vol. 21 (1) , 1-7
Open AccessPreserFlo MicroShunt® exposure: a case series
Background: PreserFlo® MicroShunt (PM) (also known as InnFocus® MicroShunt) is a subconjunctival stent implanted ab externo via a minimally invasive surgical procedure. The current indication is progressive, mild to moderate, open angle glaucoma uncontrolled on topical medications. According to the literature, adverse events are rare, mild and transient. Case presentation: Two cases of stand-alone PreserFlo MicroShunt® implantation in patients with uncontrolled open-angle glaucoma are reported. Exposure occurred 7 days and 3 months respectively after implantation. These cases shared common features including preexisting blepharitis and the lack of a Tenon’s flap. In both cases, removal of the device was required after several attempts at repair. Conclusions: PreserFlo MicroShunt® exposure is a potentially vision-threatening complication because of the risk of endophthalmitis. Potential risk factors include the absence of a Tenon’s flap and pre-existing ocular surface inflammation. Ocular surface inflammation should be detected and treated prior to PM implantation. If a deficiency in Tenon’s capsule is noted intraoperatively, close monitoring should be performed because of the higher risk of PM exposure.
- 1 February 2020
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 43 (2) , e77-e79
Early detection of multiple retinal hamartomas during the follow-up of an infant diagnosed with tuberous sclerosis: Contribution of B-scan ultrasonography
- 1 February 2020
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 43 (2) , e77-e79
Early detection of multiple retinal hamartomas during the follow-up of an infant diagnosed with tuberous sclerosis: Contribution of B-scan ultrasonography
- Open Access
- 11 October 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (10) , 1660
Sensitivity and Specificity of Ultrawide-Field Fundus Photography for the Staging of Sickle Cell Retinopathy in Real-Life Practice at Varying Expertise Level
Purpose: To evaluate the sensitivity and specificity of ultrawide-field fundus photography (UWF-FP) for the detection and classification of sickle cell retinopathy (SCR) by ophthalmologists with varying degrees of expertise in retinal disease. Methods: Patients presenting with sickle cell disease (SCD) in the Créteil University Eye Clinic, having undergone UWF-FP and ultrawide-field fluorescein angiography (UWF-FA) on the same day, were retrospectively included. Eyes with previous retinal photocoagulation were excluded. SCR was graded independently by UWF-FP and UWF-FA using Goldberg classification by two ophthalmologists with varying expertise levels. Results: Sixty-six eyes of 33 patients were included in the study. The sensitivity of UWF-FP for the detection of proliferative SCR was 100%, (95% confidence interval [CI95%] 76.8–100) for the retinal specialist and 100% (CI95% 71.5–100) for the ophthalmology resident. The specificity of UWF-FP for the detection of proliferative SCR was 100% (CI95% 92.7–100) for the retinal specialist and 98.1% (CI95% 89.7–100) for the ophthalmology resident. Conclusions: UWF-FP is a valuable exam for proliferative SCR screening, with excellent sensitivity and specificity and a good inter-grader agreement for ophthalmologists with various degree of skills, and is easy to use in a real-life setting.
- 11 October 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (10) , 1660
Open AccessSensitivity and Specificity of Ultrawide-Field Fundus Photography for the Staging of Sickle Cell Retinopathy in Real-Life Practice at Varying Expertise Level
Purpose: To evaluate the sensitivity and specificity of ultrawide-field fundus photography (UWF-FP) for the detection and classification of sickle cell retinopathy (SCR) by ophthalmologists with varying degrees of expertise in retinal disease. Methods: Patients presenting with sickle cell disease (SCD) in the Créteil University Eye Clinic, having undergone UWF-FP and ultrawide-field fluorescein angiography (UWF-FA) on the same day, were retrospectively included. Eyes with previous retinal photocoagulation were excluded. SCR was graded independently by UWF-FP and UWF-FA using Goldberg classification by two ophthalmologists with varying expertise levels. Results: Sixty-six eyes of 33 patients were included in the study. The sensitivity of UWF-FP for the detection of proliferative SCR was 100%, (95% confidence interval [CI95%] 76.8–100) for the retinal specialist and 100% (CI95% 71.5–100) for the ophthalmology resident. The specificity of UWF-FP for the detection of proliferative SCR was 100% (CI95% 92.7–100) for the retinal specialist and 98.1% (CI95% 89.7–100) for the ophthalmology resident. Conclusions: UWF-FP is a valuable exam for proliferative SCR screening, with excellent sensitivity and specificity and a good inter-grader agreement for ophthalmologists with various degree of skills, and is easy to use in a real-life setting.